Financial News
More News
View More
What SSE (SSE) Said on Its H1 Earnings Call ↗
Today 7:13 EST
What British Land (BLND) Said on Its H1 Earnings Call ↗
Today 7:13 EST
What Ithaca Energy (ITH) Said on Its Q3 Earnings Call ↗
Today 7:13 EST
Recent Quotes
View More
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

(PRLeap.com) Vienna, Austria - May 9th 2025 - Biomay, a leading manufacturer of recombinant proteins, today announced the commercial availability of its CRISPR/Cas9 nuclease, marking a significant addition to its off-the-shelf product portfolio for genome-editing applications.